Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term Deferred TaxLong-Term InvestmentsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesProperty, Plant & Equipment (Net)Retained EarningsSecuritiesSecurities - Held-to-maturitySecurities - Mortgage Backed SecuritiesSecurities - TradableShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hanover Bancorp (HNVR) Cash & Equivalents: 2020-2025

Historic Cash & Equivalents for Hanover Bancorp (HNVR) over the last 5 years, with Sep 2025 value amounting to $167.6 million.

  • Hanover Bancorp's Cash & Equivalents rose 18.65% to $167.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $167.6 million, marking a year-over-year increase of 18.65%. This contributed to the annual value of $162.9 million for FY2024, which is N/A change from last year.
  • Per Hanover Bancorp's latest filing, its Cash & Equivalents stood at $167.6 million for Q3 2025, which was up 1.84% from $164.5 million recorded in Q2 2025.
  • Hanover Bancorp's Cash & Equivalents' 5-year high stood at $211.5 million during Q2 2023, with a 5-year trough of $77.5 million in Q1 2021.
  • Its 3-year average for Cash & Equivalents is $169.1 million, with a median of $164.5 million in 2025.
  • Per our database at Business Quant, Hanover Bancorp's Cash & Equivalents skyrocketed by 107.64% in 2021 and then slumped by 33.29% in 2024.
  • Hanover Bancorp's Cash & Equivalents (Quarterly) stood at $115.0 million in 2021, then spiked by 32.49% to $152.3 million in 2022, then rose by 16.36% to $177.2 million in 2023, then decreased by 8.10% to $162.9 million in 2024, then increased by 18.65% to $167.6 million in 2025.
  • Its Cash & Equivalents stands at $167.6 million for Q3 2025, versus $164.5 million for Q2 2025 and $160.2 million for Q1 2025.